Pancreatic Cancer Research

ResearcherUniversity of Virginia Health SystemActive in the last 2 years

David F. Kashatus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8007-0612; OpenAlex author ID A5040920182; NIH RePORTER profile ID 8831084. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
25
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 grant · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 6

  1. Reactivation of DRP1 plays a functional role in resistance to MEK inhibition in pancreatic cancer cells. Last author DOI 10.1038/s41416-026-03542-7↗
  2. PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-24-4501↗
  3. KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-25-2630↗
  4. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer. Co-author DOI 10.1038/s41418-024-01310-9↗
  5. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Co-author DOI 10.1016/j.devcel.2022.04.014↗
  6. Targeting eNOS in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-0057↗

Grants 1

  1. Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis R01CA200755↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Todd W. Bauer · 4 shared papers, 2022–2026 · strength 0.94
  2. G. Aaron Hobbs · 3 shared papers, 2024–2026 · strength 0.66
  3. Salma Sharmin · 2 shared papers, 2024–2026 · strength 0.50
  4. Rachel A. Burge · 2 shared papers, 2026 · strength 0.49
  5. Christopher M Counter · 2 shared papers, 2012–2026 · strength 0.24
  6. Lu Han · 1 shared paper, 2026 · strength 0.21
  7. Christabelle Rajesh · 1 shared paper, 2026 · strength 0.21
  8. Victoria K. Spadafora · 1 shared paper, 2026 · strength 0.21
  9. Denis C. Guttridge D · 1 shared paper, 2026 · strength 0.21
  10. Thomas B. McFall · 1 shared paper, 2026 · strength 0.21
  11. Channing J. Der · 1 shared paper, 2026 · strength 0.21
  12. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.21
  13. Michael C. Ostrowski · 1 shared paper, 2026 · strength 0.21
  14. Thibaut Barnoud · 1 shared paper, 2024 · strength 0.17
  15. Giulia D. S. Ferretti · 1 shared paper, 2024 · strength 0.17
  16. John P O'Bryan · 1 shared paper, 2024 · strength 0.17
  17. David Tsai Ting · 1 shared paper, 2022 · strength 0.12
  18. William L. Hwang · 1 shared paper, 2022 · strength 0.12
  19. Harun Öztürk · 1 shared paper, 2022 · strength 0.12
  20. Turan Tufan · 1 shared paper, 2022 · strength 0.12
  21. Mazhar Adli · 1 shared paper, 2022 · strength 0.12
  22. Nabeel M. Bardeesy · 1 shared paper, 2022 · strength 0.12
  23. Sarbajeet Nagdas · 1 shared paper, 2022 · strength 0.12
  24. Benjamin L. Lampson · 1 shared paper, 2012 · strength 0.03
  25. Rebekah Ruth White · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.